The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says CVS Health's Caremark Rx, Cigna's Express Scripts and United Health Group's OptumRx ...
Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
The FTC in July issued a scathing interim report saying that Cigna/Express Scripts, CVS Health and UnitedHealth Group ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
The company presented data in June finding that 200-unit reservoirs have enough capacity for only 38% of adults for 72-hour wear, while 300-unit reservoirs would have enough capacity for 64% of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback